Jason Francis, Co-Founder, Randy Beimel, Founder and CEO, Mihail Blagoev, Co-Founder and Vice PresidentRandy Beimel co-founded Global Regenerative Group along with his colleagues Jason Francis and Mihail Blagoev after recognizing the immense potential of the advancements in regenerative medicine. They invested in a new technology for harvesting bone marrow and stem cells for regenerative medicine. The feasibility of these therapies was assessed through insights from medical professionals and business associates across Europe.
Global Regenerative Group started by distributing a single medical device focused on orthopedic medicine and later expanded its portfolio to offer a wide range of products across various medical fields. This includes solutions for hair growth, urology and gynecology, as well as neurological conditions like autism and cerebral palsy, enabling the company to address various medical challenges and solidify its market position.
"Our goal is to make regenerative medicine accessible and effective, improving patient outcomes and advancing the field," says Beimel, founder and CEO.
The educational component of the company's mission is aimed at bridging the knowledge gap among doctors, notably those whose training predates the advent of regenerative medicine and lack exposure to these new techniques.
Our goal is to make regenerative medicine accessible and effective, improving patient outcomes and advancing the field
A compelling advantage of the Global Regenerative Group is its dedication to exceptional customer service in the highly competitive medical device industry. Supporting doctors and patients with cutting-edge technologies, sample products and comprehensive training ensures that regenerative medicine continues to evolve and thrive. It goes above and beyond to foster strong relationships and trust within the medical community. Despite the significant progress made in regenerative medicine, persistent challenges remain in educating and raising awareness about advancements. Outdated perceptions of stem cells, including misconceptions about cloning, persist among many doctors and patients, impeding the widespread acceptance and utilization of regenerative treatments. The regulatory environment and insurance coverage for these treatments also varies significantly across different countries, further complicating the landscape. It assists doctors in understanding these complexities to ensure they can offer regenerative treatments without imposing financial burdens on patients, enhancing accessibility and feasibility.
Global Regenerative Group aims to improve patients’ lives worldwide by pushing the boundaries in regenerative medicine. It unites doctors from regions like the U.S., Europe, the Middle East and Asia by facilitating global sharing of ideas and best practices. The company’s network of over 3,000 doctors exemplifies its inclusive and innovative approach, continuously refining medical techniques and staying ahead of emerging trends.
Its pioneering approach, combined with a strong focus on education and customer service, has positioned it as a trusted leader. Global Regenerative Group’s commitment to improving patient care and supporting medical professionals remains strong, promising a future where regenerative medicine becomes a cornerstone of healthcare worldwide.


